A most recent report indicated that the low frequency of circulating CD8+ CCR7+ T cells is a significant risk factor for tumor recurrence in patients with head and neck cancer [14], suggesting that skewed distribution of functionally distinct CD8+ T-cell subset may occur during cancer progression. The gene discussed is CD8A; the disease is neoplasm.